𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation

✍ Scribed by Oswaldo Lorenzo-Betancor; Lluís Samaranch; Mario Ezquerra; Eduardo Tolosa; Elena Lorenzo; Jaione Irigoyen; Carles Gaig; María A. Pastor; Alexandra I. Soto-Ortolaza; Owen A. Ross; María C. Rodríguez-Oroz; Francesc Valldeoriola; María J. Martí; María R. Luquin; Jordi Perez-Tur; Juan A. Burguera; José A. Obeso; Pau Pastor

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
1006 KB
Volume
27
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background and objective.

Mutations in the Leucine‐Rich Repeat Kinase 2 (LRRK2) gene at chromosome 12q12 are the most common genetic cause of sporadic and familial late‐onset Parkinson's disease. Our aim was to identify novel LRRK2 mutations in late‐onset Parkinson's disease families.

Design.

We analyzed chromosome 12p11.2‐q13.1 haplotypes in 14 late‐onset Parkinson's disease families without known LRRK2 mutations.

Results.

Haplotype analysis identified 12 families in which the affected subjects shared chromosome 12p11.2‐q13.1 haplotypes. LRRK2 sequencing revealed a novel co‐segregating missense mutation in exon 36 (c.5281A>C; p.S1761R) located within a highly conserved region of the COR [C‐terminal of ROC (Ras of complex proteins)] domain wherein it could deregulate LRRK2 kinase activity by modifying ROC‐COR dimer stability. p.S1761R was present in a late‐onset Parkinson's disease family and in 2 unrelated Parkinson's disease subjects, but not in 2491 healthy controls. LRRK2 p.S1761R carriers developed levodopa‐responsive asymmetrical parkinsonism, with variable age at onset (range: 37–72 years) suggesting age‐dependent penetrance. These findings indicate that mutations interfering with LRRK2 ROC‐COR domain dimerization lead to typical Parkinson's disease. © 2011 Movement Disorder Society

📜 SIMILAR VOLUMES

A novel LRRK2 mutation in an Austrian co
A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease
✍ Dietrich Haubenberger; Silvia Bonelli; Christoph Hotzy; Petra Leitner; Peter Lic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract To investigate the frequency of mutations in the Leucine‐Rich Repeat Kinase 2 gene (__LRRK2__) in a sample of Austrian Parkinson's disease (PD) patients, we sequenced the complete coding region in 16 patients with autosomal dominant PD. Furthermore, we sequenced exons 31, 35, and 41 add

R1514Q substitution in Lrrk2 is not a pa
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation
✍ William C. Nichols; Diane K. Marek; Michael W. Pauciulo; Nathan Pankratz; Cheryl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract Mutations in __LRRK2__ were first reported as causing Parkinson's disease (PD) in late 2004. Since then, approximately a dozen __LRRK2__ substitutions have been identified that are believed to be pathogenic mutations. The substitution of adenine for guanine at nucleotide 4541 (4541G>A)

Analysis of Lrrk2 R1628P as a risk facto
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
✍ Owen A. Ross; Yih-Ru Wu; Mei-Ching Lee; Manabu Funayama; Meng-Ling Chen; Alexand 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for __leucine‐rich repeat kinase 2 (LRRK2)__ c.4883G>C (R1628P) as a risk factor in ethnic Chine

A novel haplotype-sharing approach for g
A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease
✍ Andrew S. Allen; Glen A. Satten 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB 👁 2 views

## Abstract The large number of markers considered in a genome‐wide association study (GWAS) has resulted in a simplification of analyses conducted. Most studies are analyzed one marker at a time using simple tests like the trend test. Methods that account for the special features of genetic associ